Tamarack Advisers, LP Alkermes Plc. Transaction History

Tamarack Advisers, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$28.34 - $33.63 $708,500 - $840,750	25,000 Added 33.33%	100,000 $3.13 Million
Q1 2023 May 10, 2023	SELL	$25.31 - $29.02 $5.06 Million - $5.8 Million	-200,000 Reduced 72.73%	75,000 $2.11 Million
Q4 2022 Feb 10, 2023	BUY	$21.94 - $26.24 $1.65 Million - $1.97 Million	75,000 Added 37.5%	275,000 $7.19 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $4.4 Million - $6.37 Million	200,000 New	200,000 $4.47 Million
Q2 2019 Aug 12, 2019	SELL	$21.47 - $37.33 $3.01 Million - $5.23 Million	-140,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$28.4 - $36.49 $3.98 Million - $5.11 Million	140,000 New	140,000 $5.11 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $4.46 Million - $5.65 Million	-110,000 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$53.61 - $67.26 $3.75 Million - $4.71 Million	-70,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $3.34 Million - $3.88 Million	70,000	70,000 $3.83 Million

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.58B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.